AURA

Aura Biosciences Inc

Price

$6.04

return (12m)

-0.17%

p/e

-4.37

p/bv

1.82

DIVIDEND YIELD

0.00%

AURA price

Aura Biosciences Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AURA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-19.36%

3 months

-16.52%

1 year

-0.17%

2 years

-30.73%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals AURA

Valuation

P/E

-4.37

Sector 7.50

Industry 7.50

P/BV

1.82

Sector 1.77

Industry 1.77

P/Revenue (PSR)

Sector 1.72

Industry 1.72

EV/EBITDA

-5.21

Sector -842.79

Industry -842.79

EV/EBIT

-5.18

Sector -1,519.48

Industry -1,519.48

P/EBITDA

-4.18

Sector -14.40

Industry -14.40

P/EBIT

-4.15

Sector -12.63

Industry -12.63

P/Total Assets

1.65

Sector 0.83

Industry 0.83

P/Net Current Assets

1.93

Sector -1.96

Industry -1.96

P/Working Capital

1.85

Sector -4,656.37

Industry -4,656.37

EPS

-1.38

Sector 0.70

Industry 0.70

BVPS

3.32

Sector 9.63

Industry 9.63

Efficiency

Gross Margin

0.00%

Sector 35.53%

Industry 35.53%

EBITDA Margin

Sector -7,056,892.18%

Industry -7,056,892.18%

EBIT Margin

Sector -159.46%

Industry -159.46%

Operating Margin

0.00%

Sector 4.35%

Industry 4.35%

Net Profit Margins

0.00%

Sector 2.37%

Industry 2.37%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-41.56%

Sector 2.14%

Industry 2.14%

ROA

-37.63%

Sector -0.82%

Industry -0.82%

ROIC

-721.35%

Sector -120.08%

Industry -120.08%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

Sector 10.02%

Industry 10.02%

Debt

Current Ratio

16.82

Sector 1.47

Industry 1.47

Net Debt / EBITDA

6.77

Sector -20.49

Industry -20.49

Net Debt / EBIT

6.74

Sector -168,192,801.50

Industry -168,192,801.50

Net Debt / Equity

-1.03

Sector -0.78

Industry -0.78

Gross Debt / Equity

0.00

Sector -0.51

Industry -0.51

Equity/Assets

0.91

Sector 0.43

Industry 0.43

Liabilities/Assets

0.09

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

40.87%

Sector -

Industry -

Fundamentals AURA

DRAG THE FRAME TO SEE MORE DATA

AURA - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Aura Biosciences Inc

Aura Biosciences Inc

Average Investor10 user rating

4.0 (3 people)

United States

- year

Founded:

2021

Time since IPO - 5 years

113

Employees

Aura Biosciences Inc (United States) is listed on the Nasdaq and has a market capitalization of $572.97 million, with shareholders equity totaling $315.27 million.

The company employs approximately 113 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Aura Biosciences Inc reported $- in revenue, generating net income of $-131.01 million.

Key financial metrics include a P/E ratio of -4.37, a price-to-book (P/B) ratio of 1.82, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AURA.

Market cap

$572.97 million

Net worth

$315.27 million

$315,267,000.00

Assets

$348.13 million

$348,129,000.00

Total Shares Outstanding

94.86 million

94,863,000

Average Daily Trading Volume

$813.82 Thousand

$813,815.68

Sector

Others

Industry

Others

AURA

AURA revenue and profits

Financial Results AURA

DRAG THE FRAME TO SEE MORE DATA

AURA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$368.07 4,90% (12M)

P/E

23.51

2.46%

ROE

13.51%

P/BV

3.18

SHEL - Shell PLC ADR

$95.74 35,65% (12M)

P/E

10.30

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.37 --59,26% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$307.21 2,24% (12M)

P/E

22.61

0.78%

ROE

81.03%

P/BV

18.32

ALIZY - Allianz SE ADR

$46.75 --19,31% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$84.50 48,84% (12M)

P/E

6.86

4.78%

ROE

21.42%

P/BV

1.47

NSRGY - Nestle SA ADR

$90.02 0,79% (12M)

P/E

10.81

4.45%

ROE

58.05%

P/BV

6.27

ELV - Elevance Health Inc

$386.86 12,56% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96